Clal Biotechnology Industries Ltd.

Tel Aviv Stock Exchange CBI.TA

Clal Biotechnology Industries Ltd. Price to Book Ratio (P/B) on January 14, 2025

Clal Biotechnology Industries Ltd. Price to Book Ratio (P/B) is NA on January 14, 2025, a NA change year over year. Price to book ratio compares the stock price to the book value per share; above 1 indicates market values company more than its book value.
  • Clal Biotechnology Industries Ltd. 52-week high Price to Book Ratio (P/B) is NA on January 14, 2025, which is NA below the current Price to Book Ratio (P/B).
  • Clal Biotechnology Industries Ltd. 52-week low Price to Book Ratio (P/B) is NA on January 14, 2025, which is NA below the current Price to Book Ratio (P/B).
  • Clal Biotechnology Industries Ltd. average Price to Book Ratio (P/B) for the last 52 weeks is NA.
Key data
Date Price to Book Ratio (P/B) Dividend Yield Free Cash Flow Yield Price to Earnings Ratio (P/E)
Market news
Loading...
Tel Aviv Stock Exchange: CBI.TA

Clal Biotechnology Industries Ltd.

CEO Dr. Avraham Matityahu Fischer M.D.
IPO Date June 4, 2007
Location Israel
Headquarters Azrieli Center
Employees 146
Sector Finance
Industries
Description

Clal Biotechnology Industries Ltd. is a private equity and venture capital firm specializing in development stage, pre-clinical; incubation, seed, start-up, early venture, emerging growth, mid venture, late venture, PIPEs, and growth capital stages of financing. It prefers to invest in life sciences, medical devices, biopharmaceutical technologies, and biotechnology companies. The firm seeks to invest in companies based in United States, and Israel. It invests between $0.5 million and $10 million per company. It takes a seat on the board of directors of the companies it invests in. It invests through personal capital of its management. The firm acts as a lead investor and major shareholder in its portfolio companies. Clal Biotechnology Industries Ltd. was founded in July, 1998 and is based in Tel Aviv, Israel with an additional office in Cambridge, Massachusetts. It operates as a former subsidiary of Clal Industries and Investments Ltd.

Similar companies

BLRX.TA

BioLineRx Ltd.

USD 0.01

-11.50%

CGEN.TA

Compugen Ltd.

USD 1.85

10.75%

BEZQ.TA

Bezeq The Israel Telecommunication Corp. Ltd

USD 1.56

3.32%

KMDA.TA

Kamada Ltd.

USD 7.30

-3.84%

EVGN.TA

Evogene Ltd.

USD 1.59

0.10%

StockViz Staff

January 15, 2025

Any question? Send us an email